NextGen Healthcare Inc (DELISTED) (NXGN:DL)
23.94
0.00 (0.00%)
USD |
NASDAQ |
Nov 14, 16:00
NextGen Healthcare Research and Development Expense (Quarterly): 18.02M for Sept. 30, 2023
Research and Development Expense (Quarterly) Chart
Historical Research and Development Expense (Quarterly) Data
Date | Value |
---|---|
September 30, 2023 | 18.02M |
June 30, 2023 | 20.92M |
March 31, 2023 | 20.03M |
December 31, 2022 | 19.62M |
September 30, 2022 | 20.86M |
June 30, 2022 | 21.80M |
March 31, 2022 | 19.43M |
December 31, 2021 | 19.39M |
September 30, 2021 | 18.52M |
June 30, 2021 | 19.32M |
March 31, 2021 | 21.39M |
December 31, 2020 | 18.20M |
September 30, 2020 | 17.69M |
June 30, 2020 | 18.22M |
March 31, 2020 | 21.43M |
December 31, 2019 | 20.03M |
September 30, 2019 | 19.79M |
June 30, 2019 | 22.05M |
March 31, 2019 | 19.81M |
December 31, 2018 | 20.68M |
September 30, 2018 | 18.37M |
June 30, 2018 | 22.13M |
March 31, 2018 | 21.10M |
December 31, 2017 | 20.64M |
September 30, 2017 | 19.53M |
Date | Value |
---|---|
June 30, 2017 | 19.99M |
March 31, 2017 | 22.11M |
December 31, 2016 | 19.71M |
September 30, 2016 | 18.29M |
June 30, 2016 | 18.22M |
March 31, 2016 | 16.08M |
December 31, 2015 | 14.52M |
September 30, 2015 | 17.98M |
June 30, 2015 | 17.08M |
March 31, 2015 | 17.64M |
December 31, 2014 | 18.47M |
September 30, 2014 | 16.90M |
June 30, 2014 | 16.24M |
March 31, 2014 | 15.12M |
December 31, 2013 | 13.18M |
September 30, 2013 | 7.615M |
June 30, 2013 | 5.614M |
March 31, 2013 | 8.231M |
December 31, 2012 | 7.786M |
September 30, 2012 | 6.272M |
June 30, 2012 | 8.576M |
March 31, 2012 | 8.907M |
December 31, 2011 | 8.277M |
September 30, 2011 | 7.358M |
June 30, 2011 | 6.827M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
17.69M
Minimum
Sep 2020
22.05M
Maximum
Jun 2019
19.82M
Average
19.70M
Median